Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
All presented with high gamma-glutamyl transpeptidase cholestasis and hepatitis.
|
30628989 |
2019 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The results revealed that the serum levels of alanine aminotransferase, aspartate aminotransferase, total bilirubin, direct bilirubin, γ‑glutamyl transpeptidase, and alkaline phosphatase were reduced in rats with ANIT‑induced cholestasis that were treated with MT.
|
30226547 |
2018 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Marker for cholestasis as total and individual serum BAs, bilirubin, alkaline phosphatase (AP), and gamma-glutamyl transpeptidase (GGT) were analyzed in patients screened for HPS.
|
27951601 |
2017 |
Cholestasis
|
0.100 |
GeneticVariation
|
disease |
BEFREE |
As low or normal gamma-glutamyl transpeptidase (GGT) activity has been described in all patients with ARC syndrome identified so far, ARC syndrome is a possible diagnosis for low GGT cholestasis.
|
24782640 |
2014 |
Cholestasis
|
0.100 |
AlteredExpression
|
disease |
BEFREE |
Cholestasis occurred before (n = 5) or after (n = 3) ITx and was characterized by intermittent jaundice, intractable pruritus, increased serum bile acid (BA) levels, and normal gamma-glutamyl transpeptidase activity.
|
24375397 |
2014 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
We describe the clinical course of 6 patients who developed recurrent low gamma-glutamyl transpeptidase cholestasis, that mimicks BSEP disease, following transplantation.
|
20583290 |
2010 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Alagille syndrome (AGS) frequently presents with neonatal jaundice and can mimic other causes of high gamma-glutamyl transpeptidase (GGT) cholestasis, most notably biliary atresia.
|
20601899 |
2010 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Homozygous mutations in the ATP8B1 gene cause cholestasis with a normal serum gamma-glutamyl transpeptidase (gamma-GT), and have been reported in two forms of cholestasis: progressive familial intrahepatic cholestasis type 1 (PFIC1) and benign recurrent intrahepatic cholestasis (BRIC).
|
15888793 |
2005 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
The present case, which accumulates the 3 clinical disorders assocaited with MDR3 deficiency, shows that this condition should be suspected not only in children or young people with high gamma-glutamyl transpeptidase cholestasis but also in middle-aged or older patients with chronic idiopathic cholestasis, especially when there is a previous history of cholestasis of pregnancy or juvenile cholelithiasis.
|
12671900 |
2003 |
Cholestasis
|
0.100 |
Biomarker
|
disease |
BEFREE |
Biochemical liver abnormalities are consistent with the presence of cholestasis and include an elevation of both serum alkaline phosphatase and gamma-glutamyl transpeptidase, with or without elevation of aminotransferase levels.
|
11918275 |
2001 |